This case report describes the administration of idarucizumab for reversing the effect of dabigatran in a patient with acute kidney injury and bleeding.
No takes yet. Share an insight, caveat, or question.
Viard et al. (2016) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: